Where does a distributor's profit actually come from?

Overwhelmingly from reagent re-orders, not the analyzer. Every installed analyzer is a locked-in stream of reagent purchases for the life of the instrument, which is years. The analyzer sale may be thin or even break-even; the margin lives in the repeat reagent business it secures.

Why is the analyzer often sold cheaply or placed?

Because the analyzer is the entry point to a long reagent relationship. A distributor who wins the analyzer placement wins the reagent stream that follows. That is why instrument pricing can be aggressive — the lifetime value of the reagent stream is worth far more than the upfront margin on the box.

What makes a reagent line profitable to distribute?

Four things: a broad test menu (more analytes per installed analyzer), a stable installed base (each analyzer is a recurring order), good margins on the consumable, and reliable supply with good shelf life (low waste and low write-off). The combination determines the quality of the recurring revenue.

What is the role of OEM/ODM in the economics?

OEM/ODM lets a distributor build a private-label line on the manufacturer's platform — capturing the brand margin as well as the distribution margin. Instead of reselling someone else's brand, the distributor owns the brand and keeps the full channel margin, at the cost of carrying the regulatory and marketing burden.

How is pricing typically structured?

Pricing is quoted against volume and terms — not a flat retail list. A distributor's price depends on order volume, regional territory, and whether the product is branded or OEM. The important discipline is to model the reagent TCO and the re-order cadence, not to compare flat list prices, because the real economics live in the recurring stream.

Distributor Economics: How Reagent Kits Actually Make Money

Q: How does the diagnostic business model actually work?

It is a classic razor-and-blades model. The analyzer is the razor — often sold at a modest margin, or placed to win the account — and the reagents are the blades, the recurring consumable that generates the ongoing revenue. The real, durable profit is in the reagent stream, not the one-time instrument sale.

TL;DR — Veterinary diagnostics is a textbook razor-and-blades business, and the distribution economics follow it exactly. The analyzer is the razor — often sold at a thin margin, or placed, to win the account — and the reagents are the blades, the recurring consumable that generates the real revenue for years. The durable profit is in the reagent stream, not the one-time instrument: every installed analyzer is a locked-in series of reagent re-orders for the life of the machine. What makes a line worth distributing is a broad test menu, a stable installed base, good consumable margins, and reliable supply — and the way to expand the margin is OEM/ODM, where the distributor owns the brand and keeps the full channel margin instead of reselling someone else’s.

In Plain Terms

Selling a diagnostic system is like selling a razor. You do not make your money on the razor — you make it on the blades the customer buys every month for years. The analyzer is the razor; the reagent kits are the blades. Understand that, and the whole economics of the business snaps into focus.

The Razor-and-Blades Structure

Component	Role	Margin profile
Analyzer	Entry point, wins the account	Thin, sometimes break-even or placed
Reagents	Recurring consumable	Where the durable margin lives

The strategic consequence is counterintuitive to newcomers: the instrument is not the product — the instrument is the key that unlocks the reagent stream. A distributor who fights hardest on analyzer price is fighting over the smallest part of the economics, while the reagent stream it secures is worth far more over the instrument’s life.

Why the Analyzer Is Often Placed or Discounted

Because the lifetime value of the reagent stream dwarfs the upfront margin on the box. A distributor who places an analyzer into a clinic is not giving away hardware — it is buying a multi-year reagent relationship. Every installed analyzer is a guaranteed, recurring reagent order for the life of the instrument, which is years.

This is why aggressive instrument pricing is rational, not desperate: the math works because the reagent stream is long and sticky. The risk is only when the analyzer is placed without a reagent commitment — then you have given away the razor and lost the blades too.

What Makes a Reagent Line Worth Distributing

Four attributes determine the quality of the recurring revenue:

Broad test menu — more analytes per installed analyzer means more re-order lines per account.
Stable installed base — each analyzer is a recurring order; the base is the asset.
Good consumable margins — the margin lives in the reagent, so the consumable must carry it.
Reliable supply and shelf life — low waste and low write-off protect the margin (a 2-year shelf life and matched box sizes matter).

The combination — not any single factor — is what turns a reagent line from a one-time sale into a durable income stream.

OEM/ODM: Owning the Margin

The step beyond distribution is OEM/ODM — building a private-label line on the manufacturer’s platform. The economics change fundamentally:

Distribution: you resell the manufacturer’s brand and keep the distribution margin.
OEM/ODM: you own the brand and keep the full channel margin — distribution plus brand.

The trade-off is that the OEM partner carries the regulatory, packaging and marketing burden. It is more work and more risk, but it converts a margin-share into a margin-owner position. For a distributor looking to graduate from reseller to brand, this is the path.

How Pricing Is Actually Structured

One thing to unlearn: there is no flat retail list that matters. Pricing is quoted against volume and terms — order volume, regional territory, and whether the product is branded or OEM all move the number.

The practical discipline is not to compare list prices but to model the real economics:

Reagent TCO per test (including QC, waste and shelf life).
Re-order cadence (how often the installed base reorders).
Lifetime value per analyzer (the reagent stream over the instrument’s life).

The recurring stream is the business. Everything else — the analyzer price, the list price, the one-time deal — is a distraction from that one number.

FAQ

How does the business model work?

Razor-and-blades — the analyzer wins the account, the reagents are the recurring revenue re-ordered over 5–7 years. The durable profit is in the stream.

Where does a distributor’s profit come from?

Overwhelmingly from reagent re-orders, not the analyzer. Each installed analyzer is a locked-in stream over 5–7 years (re-ordered repeatedly, not once).

Why is the analyzer sold cheaply?

Because it secures the reagent stream — the lifetime value of the consumables over 5–7 years far exceeds the upfront margin on the box.

What makes a reagent line profitable?

Broad menu, stable installed base, good consumable margins, reliable supply with a 2-year shelf life.

What is OEM/ODM’s role?

It lets a distributor own the brand and keep the full channel margin — 2 margins (distribution + brand) — instead of reselling.

How is pricing structured?

Quoted against volume and terms — not a flat list. Model reagent TCO, re-order cadence and lifetime value per analyzer (3 numbers).

Key Takeaways

It is razor-and-blades — the analyzer wins the account; the reagents are the recurring revenue, re-ordered for the instrument’s 5–7 year life, not once.
The instrument is the key, not the product — a placed analyzer buys a 5–7 year reagent relationship worth far more than the box.
4 attributes make a line worth distributing — broad menu, stable base, good margins, reliable supply (2-year shelf life, low waste).
OEM/ODM upgrades the margin — owning the brand keeps the full channel margin (2 margins: distribution + brand), at the cost of regulatory burden.
Model the stream, not the list — reagent TCO, re-order cadence and lifetime value per analyzer (3 numbers) are what matter.

References

Porter ME. Competitive strategy — razor-and-blades and lock-in economics.
Industry pricing practice — diagnostic reagent distribution models.
Migibio OEM/ODM and distribution documentation.

This content is for educational and market-orientation purposes only. Pricing is quoted against volume and terms; contact sales for a specific quote. Product specifications and OEM/ODM terms are as published by Migibio (Guangzhou Magic Biotech Co., Ltd.) and may change.